Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Darcy

Showing results (141-150 of 222) with videos related to

Pageof 23
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 3, 2005
Phase II study of gefitinib in patients with relapsed or persistent ovarian or primary peritoneal carcinoma and evaluation of epidermal growth factor receptor mutations and immunohistochemical expression: a Gynecologic Oncology Group StudyRussell J Schilder, Michael W Sill, Xiaowei Chen, et al.
Age and Ageing|November 6, 2018
The development of a Core Outcome Set for medicines management interventions for people with dementia in primary careMairead McGrattan, Heather E Barry, Cristín Ryan, et al.
Surgery|March 1, 1993
Intrahepatic portosystemic vascular stents: a bridge to hepatic transplantationE S Woodle, M Darcy, H M White, et al.
BMC Health Services Research|February 16, 2020
Improving medicines management for people with dementia in primary care: a qualitative study of healthcare professionals to develop a theory-informed interventionHeather E Barry, Laura E Bedford, Máiréad McGrattan, et al.
Gynecologic Oncology|July 4, 2008
Paclitaxel poliglumex and carboplatin as first-line therapy in ovarian, peritoneal or fallopian tube cancer: a phase I and feasibility trial of the Gynecologic Oncology GroupMark A Morgan, Kathleen M Darcy, Peter G Rose, et al.
Gynecologic Oncology|November 25, 2011
Common variants in ABCB1, ABCC2 and ABCG2 genes and clinical outcomes among women with advanced stage ovarian cancer treated with platinum and taxane-based chemotherapy: a Gynecologic Oncology Group studyChunqiao Tian, Christine B Ambrosone, Kathleen M Darcy, et al.
Gynecologic Oncology|January 21, 2012
Pre-treatment tumor expression of ERCC1 in women with advanced stage epithelial ovarian cancer is not predictive of clinical outcomes: a Gynecologic Oncology Group studyJennifer M Rubatt, Kathleen M Darcy, Chunqiao Tian, et al.
Cancer|August 28, 2019
Patient preferences for attributes of primary surgical debulking versus neoadjuvant chemotherapy for treatment of newly diagnosed ovarian cancerLaura J Havrilesky, Jui-Chen Yang, Paula S Lee, et al.
Gynecologic Oncology|April 2, 2018
Racial disparities in molecular subtypes of endometrial cancerElizabeth A Dubil, Chunqiao Tian, Guisong Wang, et al.
Gynecologic Oncology|October 7, 2008
Associations between p53 overexpression and multiple measures of clinical outcome in high-risk, early stage or suboptimally-resected, advanced stage epithelial ovarian cancers A Gynecologic Oncology Group studyKathleen M Darcy, William E Brady, John W McBroom, et al.
Pageof 23

Showing results (141-150 of 222) with videos related to

Sort By:
Pageof 23
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 3, 2005
Phase II study of gefitinib in patients with relapsed or persistent ovarian or primary peritoneal carcinoma and evaluation of epidermal growth factor receptor mutations and immunohistochemical expression: a Gynecologic Oncology Group StudyRussell J Schilder, Michael W Sill, Xiaowei Chen, et al.
Age and Ageing|November 6, 2018
The development of a Core Outcome Set for medicines management interventions for people with dementia in primary careMairead McGrattan, Heather E Barry, Cristín Ryan, et al.
Surgery|March 1, 1993
Intrahepatic portosystemic vascular stents: a bridge to hepatic transplantationE S Woodle, M Darcy, H M White, et al.
BMC Health Services Research|February 16, 2020
Improving medicines management for people with dementia in primary care: a qualitative study of healthcare professionals to develop a theory-informed interventionHeather E Barry, Laura E Bedford, Máiréad McGrattan, et al.
Gynecologic Oncology|July 4, 2008
Paclitaxel poliglumex and carboplatin as first-line therapy in ovarian, peritoneal or fallopian tube cancer: a phase I and feasibility trial of the Gynecologic Oncology GroupMark A Morgan, Kathleen M Darcy, Peter G Rose, et al.
Gynecologic Oncology|November 25, 2011
Common variants in ABCB1, ABCC2 and ABCG2 genes and clinical outcomes among women with advanced stage ovarian cancer treated with platinum and taxane-based chemotherapy: a Gynecologic Oncology Group studyChunqiao Tian, Christine B Ambrosone, Kathleen M Darcy, et al.
Gynecologic Oncology|January 21, 2012
Pre-treatment tumor expression of ERCC1 in women with advanced stage epithelial ovarian cancer is not predictive of clinical outcomes: a Gynecologic Oncology Group studyJennifer M Rubatt, Kathleen M Darcy, Chunqiao Tian, et al.
Cancer|August 28, 2019
Patient preferences for attributes of primary surgical debulking versus neoadjuvant chemotherapy for treatment of newly diagnosed ovarian cancerLaura J Havrilesky, Jui-Chen Yang, Paula S Lee, et al.
Gynecologic Oncology|April 2, 2018
Racial disparities in molecular subtypes of endometrial cancerElizabeth A Dubil, Chunqiao Tian, Guisong Wang, et al.
Gynecologic Oncology|October 7, 2008
Associations between p53 overexpression and multiple measures of clinical outcome in high-risk, early stage or suboptimally-resected, advanced stage epithelial ovarian cancers A Gynecologic Oncology Group studyKathleen M Darcy, William E Brady, John W McBroom, et al.
Pageof 23